Rashid S. Key questions resulting from the JUPITER trial assessing cardiovascular disease intervention with rosuvastatin. World J Cardiol 2009; 1(1): 41-45 [PMID: 21160575 DOI: 10.4330/wjc.v1.i1.41]
Corresponding Author of This Article
Dr. Shirya Rashid, PhD, Department of Medicine, McMaster University, Henderson Research Centre, Room 206, G-Wing, 711 Concession Street, Hamilton, Ontario, L8V 1C3, Canada. srashid@thrombosis.hhscr.org
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/